- Berenberg downgraded Bristol-Myers Squibb Co BMY from Buy to Hold. The price target for Bristol-Myers Squibb has been lowered from $80 to $70. Bristol-Myers Squibb shares rose 0.36 percent to $60.80 in pre-market trading.
- Analysts at Ladenburg Thalmann downgraded Zosano Pharma Corp ZSAN from Buy to Neutral. Zosano Pharma shares fell 2.14 percent to close at $1.37 on Wednesday.
- Scotia Howard Weil downgraded EQT Corporation EQT from Sector Outperform to Sector Perform. EQT shares dropped 0.84 percent to close at $68.25 on Wednesday.
- Analysts at Keefe Bruyette & Woods downgraded PHH Corporation PHH from Outperform to Market Perform. PHH shares declined 0.67 percent to $14.82 in pre-market trading.
- Barrington Research downgraded EPIQ Systems, Inc. EPIQ from Market Perform to Underperform. Epiq Systems shares fell 0.18 percent to $16.31 in pre-market trading.
- Nomura downgraded Lam Research Corporation LRCX from Buy to Neutral. Lam Research shares declined 4.48 percent to close at $89.11 on Wednesday.
- Analysts at Morgan Stanley downgraded Lumentum Holdings Inc LITE from Equal-weight to Underweight. The price target for Lumentum Holdings has been raised from $20 to $27. Lumentum Holdings shares rose 0.29 percent to close at $55.72 on Wednesday.
- Analysts at Evercore ISI Group downgraded Scripps Networks Interactive, Inc. SNI from Buy to Hold. Scripps Networks shares gained 1.04 percent to close at $62.11 on Wednesday.
- Ladenburg Thalmann downgraded Zosano Pharma Corp ZSAN from Buy to Neutral. Zosano Pharma shares dropped 2.14 percent to close at $1.37 on Wednesday.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
|---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
